Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C in TET2-mutated MDS
NCT03433781Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- May 2018
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ascorbic acid in myelodysplastic syndrome (MDS), sponsored by NYU Langone Health. Started May 2018; status: completed.
02
Drugs
ascorbic acid
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT03433781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03433781.